These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3652053)

  • 21. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
    Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
    Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.
    ter Haar E; Hamel E; Balachandran R; Day BW
    Anticancer Res; 1997; 17(3C):1861-9. PubMed ID: 9216636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
    Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
    Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
    Somers-Edgar TJ; Rosengren RJ
    Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of estrogen-nitrosourea conjugates with the estrogen receptor in rat uterus.
    Lam HY; Goldenberg GJ; Wong CM
    Biochem Pharmacol; 1988 Jul; 37(13):2625-31. PubMed ID: 3390222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
    Wiese TE; Polin LA; Palomino E; Brooks SC
    J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
    Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
    Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
    Chang SB; Miron P; Miron A; Iglehart JD
    J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells.
    Wei LL; Katzenellenbogen BS; Robertson DW; Simpson DM; Katzenellenbogen JA
    Breast Cancer Res Treat; 1986; 7(2):77-90. PubMed ID: 3719114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.
    Burke PJ; Koch TH
    J Med Chem; 2004 Feb; 47(5):1193-206. PubMed ID: 14971899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steroid conjugates of dichloro(6-aminomethylnicotinate)platinum(II): effects on DNA, sex hormone binding globulin, the estrogen receptor, and various breast cancer cell lines.
    Schobert R; Bernhardt G; Biersack B; Bollwein S; Fallahi M; Grotemeier A; Hammond GL
    ChemMedChem; 2007 Mar; 2(3):333-42. PubMed ID: 17266159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estradiol induction of retinoic acid receptors in human breast cancer cells.
    Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL
    Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
    Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of estrogen receptor concentration in MCF-7 human breast carcinoma cells following exposure to chemotherapeutic drugs.
    Yang KP; Samaan NA
    Cancer Res; 1983 Aug; 43(8):3534-8. PubMed ID: 6861126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific estrogen receptor binding and biological effects of 16 alpha-iodoestradiol on human breast cancer cells.
    Lippman ME; Do HM; Hochberg RB
    Cancer Res; 1981 Aug; 41(8):3150-4. PubMed ID: 7248972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
    Burke PJ; Kalet BT; Koch TH
    J Med Chem; 2004 Dec; 47(26):6509-18. PubMed ID: 15588086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
    Erber S; Ringshandl R; von Angerer E
    Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 17-beta-estradiol on doxorubicin cytotoxicity in human breast cancer cell culture.
    Toma S; Leonessa F; Coialbu T; Nicolo G; Rosso R
    Anticancer Res; 1989; 9(2):303-8. PubMed ID: 2751257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.